Cannabis Bioscience International Holdings, Inc. (CBIH) Gross Margin (2022 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted Gross Margin of 72.82% for Q1 2026, down 9.3% sequentially from 80.29% in Q4 2025, and up 10273.0% YoY from N/an in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) Gross Margin (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported Gross Margin for 5 years, with the latest figure at 72.82% in Q1 2026.
- Quarterly Gross Margin rose 10273.0% year-over-year to 72.82% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 78.78% (down 801.0% YoY) and the FY2025 annual result came in at 86.76%, up 509.0% from the prior year.
- Gross Margin slipped to 72.82% in Q1 2026 per CBIH's latest filing, from 80.29% in the prior quarter.
- Over five years, Gross Margin peaked at 95.33% in Q3 2024 and troughed at 29.9% in Q1 2025.
- A 5-year average of 70.71% and a median of 78.31% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2025 and 2026: Gross Margin plunged 9747 bps in 2025, then jumped 10273 bps in 2026.
- Over 5 years, Gross Margin stood at 91.41% in 2022, then dropped by 17 bps to 76.33% in 2023, then grew by 17 bps to 89.49% in 2024, then slipped by 10 bps to 80.29% in 2025, then slipped by 9 bps to 72.82% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 72.82%, 80.29%, and 66.35% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 72.82% |
| Nov 30, 2025 | 80.29% |
| Aug 31, 2025 | 66.35% |
| May 31, 2025 | 87.00% |
| Feb 28, 2025 | -29.90% |
| Nov 30, 2024 | 89.49% |
| Aug 31, 2024 | 95.33% |
| May 31, 2024 | 86.98% |
| Feb 29, 2024 | 67.57% |
| Nov 30, 2023 | 76.33% |
| Aug 31, 2023 | 87.89% |
| May 31, 2023 | 65.51% |
| Feb 28, 2023 | 52.94% |
| Nov 30, 2022 | 91.41% |